|
S.V. Shalaev (1, 2), Z.M. Safiullina (1), N.A. Mikhalchuk (1)
STATINS AND THE RISK FOR NEW-ONSET DIABETES: RISK-BENEFIT RATIO. MODERN VIWES ON TARGET LIPID LEVELS IN DIABETES PATIENTS
|
№16 / 2014
|
|
E.V. Doskina
DIABETES MELLITUS AND OSTEOPOROSIS. ANALYSIS OF COMBINED APPROACH TO THE TREATMENT
|
№s5-14 / 2014
|
|
I.V. Maev, A.N. Kazyulin, S.M. Babina
THE USE OF USING DRUGS MADE BY NEW TECHNOLOGIES IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
|
№14 / 2014
|
|
D.V. Akimova
RISK FACTORS FOR OSTEOPOROSIS
|
№7 / 2014
|
|
N.Yu. Arbatskaya (1,2)
FEATURES OF GLUCOSE-LOWERING TREATMENT DURING PREGNANCY
|
№5 / 2014
|
|
I.V. Kononenko, O.M. Smirnova
DIABETES MELLITUS: FROM UNDERSTANDING OF CAUSES TO THE CHOICE OF TREATMENT
|
№5 / 2014
|
|
L.A. Sharonova (1), A.F. Verbovoy (1), D.Yu. Sharonova (2)
CLINICAL MANIFESTATION, DIAGNOSIS AND TREATMENT OF DIABETIC NEUROPATHY
|
№5 / 2014
|
|
O.L.Badalyan , A.A.Savenkov
PATHOGENETIC APPROACHES TO THE THERAPY OF DIABETIC POLYNEUROPATHY
|
№5 / 2014
|
|
M.E.Statsenko (1), A.A.Vinnikova (1), N.N.Shilina (1), A.M.Ronskaya (2)
POTENTIALS OF DIBICOR IN IN CORRECTION OF METABOLIC AND VASCULAR ABNORMALITIES IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
E.V. Biryukova, T.B. Danilova
PHARMACOTHERAPY OF DIABETIC NEUROPATHY: WHAT ELSE EXCEPT GLYCEMIC CONTROL?
|
№16 / 2013
|
|
I.A. Kurnikova
METABOLIC SYNDROME IN DIABETIC PATIENTS AND ITS CORRECTION USING THIOCTIC ACID PREPARATIONS
|
№16 / 2013
|
|
I.A.Kurnikova
THIOCTIC ACID PREPARATIONS IN THE TREATMENT OF ERECTILE DYSFUNCTION IN DIABETIC PATIENTS
|
№12 / 2013
|
Русский
